Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Female pseudohermaphroditism]

H Kamijo1, O Narita

  • 1Department of OB/GYN, Narita Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 13, 1997
PubMed
Summary
This summary is machine-generated.

Female pseudohermaphroditism involves virilized external genitalia in XX individuals, often caused by congenital adrenal hyperplasia (CAH). Early treatment can enable normal puberty, fertility, and childbearing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extranodal natural killer/T-cell lymphoma, nasal type with CCR3 and CXCR3 expression.

Clinical and experimental dermatology·2020
Same author

Sum frequency generation spectroscopic studies on phase transitions of phospholipid monolayers containing poly(ethylene oxide) lipids at the air-water interface.

The journal of physical chemistry. B·2007
Same author

Chronic Japanese schistosomiasis and hepatocellular carcinoma: ten years of follow-up in Yamanashi Prefecture, Japan.

Bulletin of the World Health Organization·1999
Same author

Assessment of human sperm functional changes after in-vitro coincubation with cells retrieved from the human female reproductive tract.

Human reproduction (Oxford, England)·1993
Same author

Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation.

Fertility and sterility·1993
Same author

Dissociation of collagenase-tissue inhibitor of metalloproteinases-1 (TIMP-1) complex--its application for the independent measurements of TIMP-1 and collagenase activity in crude culture media and body fluids.

Matrix (Stuttgart, Germany)·1992

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Context:

  • Female pseudohermaphroditism presents with female internal genitalia and XX karyotype, alongside varying degrees of external virilization.
  • Congenital adrenal hyperplasia (CAH), primarily 21-hydroxylase deficiency, is the leading cause of virilized external genitalia in female fetuses exposed to excess androgens.

Purpose:

  • To outline the causes, diagnosis, and management of female pseudohermaphroditism, focusing on congenital adrenal hyperplasia.
  • To highlight the importance of hormonal therapy and surgical correction for CAH.
  • To discuss the utility of HLA typing for genetic screening and the potential for prenatal diagnosis.

Summary:

  • Female pseudohermaphroditism results from congenital androgen excess, with CAH (21-hydroxylase deficiency) being the most common etiology. Maternal androgen excess from tumors or drugs can also be responsible.

Related Experiment Videos

  • Management involves a combination of hormonal therapy and surgical intervention. Successful treatment facilitates normal pubertal development, fertility, and reproductive capabilities.
  • Genetic analysis, including HLA typing due to gene linkage, aids in identifying carriers and affected individuals. Prenatal diagnosis is feasible, though prenatal treatment for CAH remains under development.

    • Impact:

    • Establishes that timely and appropriate treatment for female pseudohermaphroditism can lead to positive long-term outcomes, including normal puberty and reproductive health.
    • Emphasizes the role of genetic diagnostics and family screening in managing CAH and related conditions.
    • Underscores the need for further research into established prenatal treatment strategies for congenital adrenal hyperplasia.